Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense

Journal of Immunology

Volumn 165, Issue 11, 2000, Pages 6496-6503

  Chen, G H ^a   Reddy, R C ^a   Newstead, M W ^a   Tateda, K ^a   Kyasapura, B L ^a   Standiford, T J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ASSAY; FEMALE; GENE THERAPY; HOST RESISTANCE; IMMUNOSTIMULATION; LUNG; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; SURVIVAL; TRANSGENE;

EID: 0034547960     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.11.6496     Document Type: Article

References (66)

1. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis
2. The risk factors, incidence, and prognosis of ARDS following septicemia
3. Adult respiratory distress syndrome: Risk with common predispositions
4. Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia: A common clinical sequence
5. Causes of mortality in patients with the adult respiratory distress syndrome
6. Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome
7. Pneumonia complicating adult respiratory distress syndrome
8. Ventilator-associated pneumonia due to Pseudomonas aeruginosa
9. Acute respiratory distress syndrome and nosocomial pneumonia
10. Dysregulation of in vitro cytokine production by monocytes during sepsis
11. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections
12. Balance of inflammatory cytokines related to severity and mortality of murine sepsis
13. Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin
14. Cytokines and anticytokines in the pathogenesis of sepsis
15. Immune dysfunction in murine polymicrobial sepsis: Mediators, macrophages, lymphocytes and apoptosis
16. Immunopathologic alterations in murine models of sepsis of increasing severity
17. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome
18. Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense?
19. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group
20. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever
21. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura
22. The complex pattern of cytokines in serum from patients with meningococcal septic shock: Association between interleukin 6, interleukin 1, and fatal outcome
23. Interleukin 1 induces a shock-like state in rabbits: Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition
24. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock
25. Provocation of pulmonary vascular endothelial injury in rabbits by human recombinant interleukin-1 β
26. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease
27. Pentoxifylline and tumour necrosis factor-induced lung injury
28. Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment
29. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
30. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group
31. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection
32. Evidence that tumor necrosis factor has an important role in antibacterial resistance
33. Intrapulmonary tumor necrosis factor gene therapy increases bacterial clearance and survival in marine Gram-negative pneumonia
34. Tumor necrosis factor and interleukin-1: Cytokines with multiple overlapping biological activities
35. Activation of the neutrophil bactericidal activity for nontypable Haemophilus influenzae by tumor necrosis factor and lymphotoxin
36. A role in vivo for tumor necrosis factor α in host defense against Chlamydia trachomatis
37. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: Elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival
38. Pulmonary infection complicating intra-abdominal sepsis: Clinical and experimental observations
39. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense
40. Adenovirus vectors for cytokine gene expression
41. Isolation and characterization of insertion mutants in E1A of adenovirus type 5
42. Adenovirus E1A under the control of heterologous promoters: Wide variation in E1A expression levels has little effect on virus replication
43. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3
44. Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector
45. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model
46. Interleukin-10 inhibits neutrophil phagocytic and bactericidal activity
47. An assessment of the respiratory burst and bactericidal activity of alveolar macrophages from adult and senescent mice
48. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits
49. The role of cytokine mediators in septic shock
50. Tumor necrosis factor (cachectin) in the biology of septic shock syndrome
51. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group
52. Cellular and molecular mechanisms of TNF protection in septic peritonitis
53. Intrapulmonary delivery of tumor necrosis factor agonist peptide augments host defense in murine Gram-negative bacterial pneumonia
54. Intraportal lipopolysaccharide suppresses pulmonary antibacterial defense mechanisms
55. Compartmentalized cytokine production within the human lung in unilateral pneumonia
56. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice
57. Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men
58. Mechanism of endotoxin desensitization: Involvement of interleukin 10 and transforming growth factor β
59. Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response
60. Enhancement by tumor necrosis factor-α of Fc α receptor expression and IgA-mediated superoxide generation and killing of Pseudomonas aeruginosa by polymorphonuclear leukocytes
61. Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumour necrosis factor-α (TNF-α) production
62. Gene transfer into inflamed glomeruli using macrophages transfected with adenovirus
63. Transient gene transfer and expression in the lung
64. Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages
65. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-α plays a critical role in maintaining secondary immunity in the absence of IFN-gamma
66. Interleukin-12 activates human γ δ T cells: Synergistic effect of tumor necrosis factor-α